Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GSK-690693
Cat. No.:
OB0225LY-0329
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR.
Size:
Product Overview
Description:
GSK-690693 is a selective inhibitor of the PI3K/Akt pathway that affects cell proliferation and survival.
Synonym:
GSK690693; 937174-76-0
CAS No.:
937174-76-0
Formula:
C21H27N7O3
Formula Weight:
425.48
Specification
Relative Density:
1.41 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
GSK-690693 can be used in tumor biology research or play an important role in the exploration of signal transduction pathways.
Library Information
Targets:
Serine/Threonine kinases
Receptors:
Akt1; Akt1; Akt3; AMPK; PKCη; PKCθ; PrkX
Pathways:
Chromatin/Epigenetic; PI3K/Akt/mTOR signaling; Autophagy; Cytoskeletal signaling; Proteases/Proteasome
Plate Number:
AOCL-5
Plate Location:
c3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
18.33 mg/mL; 43.09 mM
Solubility:
Soluble in DMF.
ALogP:
1.839
HBA_Count:
6
HBD_Count:
2
Rotatable Bond:
7
